Perlstein Lab

Perlstein Lab solves the unmet medical needs of orphan disease patients with a scalable drug candidate generator that leaves no mutation behind. Our novel platform efficiently identifies personalized orphan drug candidates on a 12-18 month innovation cycle, combining: (1) patient genetic data and natural history, (2) high-throughput drug screening of genome-edited primordial animal models, and (3) safety and efficacy validation studies in patient-derived cells.
Type
Private
HQ
San Francisco, US
Founded
2013
Employees
6 (est)
Perlstein Lab was founded in 2013 and is headquartered in San Francisco, US

Key People at Perlstein Lab

Ethan Oren Perlstein

Ethan Oren Perlstein

CEO

Perlstein Lab Locations

San Francisco, US

Perlstein Lab Metrics

Perlstein Lab Summary

Founding Date

2013

Total Funding

$7.32 M

Latest funding size

$120 K

Time since last funding

9 months

Investors

Perlstein Lab's latest funding round of $120 K was in March 2016. In total, Perlstein Lab has raised $7.32 M.

Perlstein Lab Online Presence

Perlstein Lab News

Perlstein Lab Company Life

You may also be interested in